Skip to content

Clinical study of HIIT combined with oral iron supplementation for CHF patients with iron deficiency

Clinical study of HIIT combined with oral iron supplementation for CHF patients with iron deficiency

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066923
Enrollment
Unknown
Registered
2022-12-21
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Group A:The first 12 weeks: HIIT combined with oral iron supplementation and routine nursing
After 12 weeks: oral iron supplementation and routine nursing
Group B:The first 12 weeks: oral iron supplementation and routine nursing
The second 12 weeks: HIIT combined with oral iron supplementation and routine nursing

Sponsors

Shanghai Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The New York Heart Association (NYHA) cardiac function grade II-III; (2) Independent activities of daily living before admission (ADL) (3) Self-guided walking distance of more than 4 meters after admission (walkers can be used) (4) Age above 50 and below 80 (5) Serum ferritin <100µg/L or 100 -- 300µg/L, transferrin saturation (TSAT) <20% (6) Participate in the study voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Advanced heart failure (requiring a heart transplant or left ventricular assist device within 6 months); (2) Patients with primary valvular disease (such as severe aortic stenosis or mitral insufficiency); (3) Advanced renal insufficiency (estimated glomerular filtration rate 160/100 mmHg); (6) infection, inflammatory disease or active neoplastic disease (7) severe liver insufficiency (transaminase) = 3 times the upper limit of normal value); (8) Polycythemia (hemoglobin >16 g/dL). (9) The patient has obvious cognitive impairment; (10) Patients had poor compliance or could not communicate normally.

Design outcomes

Primary

MeasureTime frame
Grading of heart function;Serum ferritin;

Secondary

MeasureTime frame
6MWT;NT-proBNP;KCCQ;

Countries

China

Contacts

Public ContactWU Xu-bo

Shanghai Seventh People's Hospital

Wuxubo320@163.com18616028857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026